EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus

Yazdan Ebrahimpour iD, Sahbasadat Khatami, Mahsa Saffar, Alireza Fereidouni, Zahra Biniaz, Nafiseh Erfanian, Mohammad Fereidouni

Journal of Diabetes · 2025-08 · 17 (8)

DOI: 10.1111/1753-0407.70120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes, online erschienen am 06.08.2025. Verfasst von Yazdan Ebrahimpour und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disorder where the immune system targets and destroys insulin‐producing β‐cells in the pancreas. It generally emerges during childhood or adolescence, but individuals of any age can be affected. In contrast to Type 2 diabetes mellitus (T2DM) which is often associated with lifestyle factors, T1DM cannot be prevented and necessitates lifelong management. Currently, there is no definitive cure for T1DM, and patients rely on continuous insulin injections for their entire lives. Ongoing developments in insulin treatment, such as insulin pumps, continuous glucose monitoring, and hybrid closed‐loop systems, offer promising alternatives. Despite advancements in intensive glycemic control that have reduced the occurrence of microvascular and macrovascular complications, a significant number of T1DM patients still these issues. Extensive research efforts are crucial to achieve early detection, prevent the loss of β‐cells, and devise improved treatment strategies to enhance the quality of life and prognosis for those affected. This review explores the most noteworthy and recent advancements in the field of T1DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HumansInsulinHypoglycemic AgentsInsulin Infusion SystemsBlood Glucose Self-MonitoringBlood Glucose

Stichwörter der Autor:innen

Type 1 diabetes mellitusgene therapyimmunotherapy

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
  • Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.

ORCID-Profile: Yazdan Ebrahimpour

Zitieren

APA

Ebrahimpour, Y., Khatami, S., Saffar, M., Fereidouni, A., Biniaz, Z., Erfanian, N., & Fereidouni, M. (2025). A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus. Journal of Diabetes, 17(8). https://doi.org/10.1111/1753-0407.70120

Vancouver

Ebrahimpour Y, Khatami S, Saffar M, Fereidouni A, Biniaz Z, Erfanian N, et al. A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus. Journal of Diabetes. 2025;17(8). doi:10.1111/1753-0407.70120

BibTeX
@article{Ebrahimpour2025,
  author = {Ebrahimpour, Yazdan and Khatami, Sahbasadat and Saffar, Mahsa and Fereidouni, Alireza and Biniaz, Zahra and Erfanian, Nafiseh and Fereidouni, Mohammad},
  title = {A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus},
  journal = {Journal of Diabetes},
  year = {2025},
  volume = {17},
  number = {8},
  doi = {10.1111/1753-0407.70120}
}
Kostenlos starten →